|

Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia

RECRUITINGN/ASponsored by Nanfang Hospital, Southern Medical University
Actively Recruiting
PhaseN/A
SponsorNanfang Hospital, Southern Medical University
Started2019-09-29
Est. completion2026-12
Eligibility
Age1 Month – 18 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06155188

Summary

To determine if the novel regimen of PT/FLU+CY promotes cord blood engraftment in children's leukemia HSCT cohort

Eligibility

Age: 1 Month – 18 YearsHealthy volunteers accepted
Inclusion Criteria:

* children acute leukemia

Exclusion Criteria:

* MODS

Conditions4

CancerCord BloodLeukemiaStem Cell Transplant

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.